Fatos Olldashi PhD (Albania)
Head of Departament of Neurosurgery, University Hospital of Trauma,
Lecturer of Neurosurgery in Medical University of Tirana
Consultant neurosurgeon American Hospital of Tirana
Members
Secretary of Albanian Society of Neurosurgery
Member of Worls Federation of Neurosurgical Surgeons.
Member of European Association of Neurosurgery, Member of Executive Comitee
Member of American Society of Neurosurgery
Member of Southeast Society of Neurosurgery, Member of Executive Comitee
Member of Organizing comitee and fuculty on International Neurosurgery Course „Walking The Silk Road“
Education
1992 – Graduated in Medical Faculty of Tirana, as General Practioner. Period attended : 1987– 1992 result 9.2/10
1994-2000 – Period of training at Dpt of neurosurgery, University Hospital Center, “Mother Teresa” Tirana.
May 2000- Graduated neurosurgeon result 10/10
2002 – Master Degree in neurosurgery.
2010 – Graduated Doctor on Medical Science (PhD)
Training
May –September 1994 – In training near the Dpt. of Neurosurgery University Hospital, Maastricht The Netherlands.
April’95-Jan1996 – In training near the Dpt. of Neurosurgery University Hospital, Aarhus Denmark.
May- October 1997 – In training near the Dpt. of Neurosurgery University Hospital
Groningen and Dpt. Of Neurosurgery University Hospital Rotterdam Holland. This was possible by EANS exchanging programs for neurosurgeons in training.
April – June 2004 – In training at Dpt. Of Neurosurgery, Iowa USA.
Research
From 2002 active participant and national coordinator for CRASH international studies.
Those studies are coordinated from London School of Hygiene and Tropical Medicine.
1-CRASH: Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomized placebo-controlled trial.
2- CRASH2: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized, placebo-controlled trial.
3- CRASH-3 – tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial.
*** More than 100 presentations in national and international medical congresses.